Table 1 Clinical characteristics of the study population stratified by SHR Tertile.
SHR tertile | |||||
|---|---|---|---|---|---|
Total patient (N = 288) | T1 (N = 89) | T2 (N = 103) | T3 (N = 96) | P value | |
General characteristics | |||||
Age (years) | 49.41 ± 16.217 | 49.91 ± 16.297 | 48 ± 16.328 | 50.46 ± 16.087 | 0.533 |
WC (cm) | 103.18 ± 17.232 | 99.22 ± 15.506 | 103.99 ± 17.149 | 106.02 ± 18.320 | 0.026 |
Male, n (%) | 137 (47.6) | 38 (42.7) | 46 (44.7) | 53 (55.2) | 0.179 |
SBP (mmHg) | 123.85 ± 17.686 | 123.22 ± 17.779 | 124.50 ± 18.041 | 123.75 ± 17.404 | 0.900 |
DBP (mmHg) | 70.04 ± 11.129 | 70.17 ± 11.084 | 71.62 ± 11.288 | 68.18 ± 10.854 | 0.140 |
BMI | 30.62 ± 7.510 | 29.96 ± 7.561 | 30.90 ± 7.109 | 30.94 ± 7.607 | 0.610 |
PIR, (%) | 2.66 ± 1.770 | 2.71 ± 1.873 | 2.91 ± 1.736 | 2.36 ± 1.678 | 0.097 |
Ethnicity, n (%) | 0.005 | ||||
Mexican American | 47 (16.3) | 11 (12.4) | 16 (15.5) | 20 (20.8) | |
Non-Hispanic White | 155 (53.8) | 41 (46.1) | 53 (51.5) | 61 (63.5) | |
Non-Hispanic Black | 34 (11.8) | 18 (20.2) | 11 (10.7) | 5 (5.2) | |
Other Ethnicity | 52 (18.1) | 19 (21.3) | 23 (22.3) | 10 (10.4) | |
Education levels, n (%) | 0.007 | ||||
Less than high school | 63 (22.0) | 14 (15.7) | 19 (18.6) | 30 (31.3) | |
High school diploma | 60 (20.9) | 14 (15.7) | 21 (20.6) | 25 (26.0) | |
More than high school | 164 (57.1) | 61 (68.5) | 62 (60.8) | 41 (42.7) | |
Marital status, n (%) | 0.349 | ||||
Married | 153 (53.3) | 52 (58.4) | 49 (48.0) | 52 (54.2) | |
Single or separated | 134 (46.7) | 37 (41.6) | 53 (52.0) | 44 (45.8) | |
Smoking status, n (%) | 0.804 | ||||
Never | 135 (47.0) | 41 (46.1) | 51 (50.0) | 43 (44.8) | |
Former | 95 (33.1) | 31 (34.8) | 29 (28.4) | 35 (36.5) | |
Current | 57 (19.9) | 17 (19.1) | 22 (21.6) | 18 (18.8) | |
Alcohol consumption | 0.957 | ||||
Yes | 209 (77.4) | 61 (76.3) | 77 (77.8) | 71 (78.0) | |
No | 61 (22.6) | 19 (23.8) | 22 (22.2) | 20 (22.0) | |
Comorbidities | |||||
DM, n (%) | 38 (13.9) | 9 (10.5) | 9 (9.3) | 20 (22.2) | 0.020 |
Hypertension, n (%) | 134 (46.9) | 41 (46.1) | 47 (46.1) | 46 (48.4) | 0.932 |
Heart failure, n (%) | 15 (5.3) | 2 (2.3) | 4 (4.0) | 9 (9.4) | 0.093 |
Stroke, n (%) | 10 (3.5) | 4 (4.5) | 2 (4.5) | 4 (4.2) | 0.567 |
CHD, n (%) | 18 (6.3) | 5 (5.6) | 5 (5.0) | 8 (8.4) | 0.576 |
CKD, n (%) | 9(3.2) | 2(2.3) | 4 (4.0) | 3(3.1) | 0.817 |
MetS, n (%) | 132 (45.8) | 33 (37.1) | 47 (45.6) | 52 (54.2) | 0.066 |
Laboratory parameters | |||||
WBC(109/L) | 7.21 ± 2.122 | 7.21 ± 2.255 | 7.37 ± 2.321 | 7.04 ± 1.748 | 0.522 |
Neutrophil (%) | 59.70 ± 9.196 | 58.02 ± 9.691 | 59.86 ± 8.769 | 61.07 ± 9.026 | 0.077 |
Lymphocyte(%) | 28.44 ± 8.065 | 29.75 ± 8.117 | 28.81 ± 7.762 | 26.83 ± 8.151 | 0.041 |
Monocyte(%) | 8.02 ± 2.281 | 8.23 ± 2.488 | 7.66 ± 2.076 | 8.22 ± 2.269 | 0.129 |
TC (mmol/L) | 5.08 ± 1.040 | 5.12 ± 1.075 | 5.10 ± 1.059 | 5.01 ± 0.993 | 0.754 |
HDL-C (mmol/L) | 1.36 ± 0.448 | 1.42 ± 0.514 | 1.31 ± 0.363 | 1.36 ± 0.464 | 0.279 |
LDL-C (mmol/L) | 3.00 ± 0.900 | 3.06 ± 0.968 | 3.05 ± 0.941 | 2.89 ± 0774 | 0.370 |
TG (mmol/L) | 1.63 ± 1.472 | 1.39 ± 0.744 | 1.62 ± 1.241 | 1.85 ± 2.058 | 0.066 |
SHR as continuous | 0.93 ± 0.129 | 0.80 ± 0.065 | 0.90 ± 0.026 | 1.07 ± 0.100 | < 0.001 |
FPG (mmol/L) | 6.03 ± 1.878 | 5.27 ± 0.923 | 5.61 ± 0.571 | 7.17 ± 2.733 | < 0.001 |
Hb1AC (%) | 5.71 ± 0.910 | 5.81 ± 0.773 | 5.54 ± 0.402 | 5.81 ± 1.313 | 0.004 |
CRP (mg/dL) | 0.56 ± 1.164 | 0.42 ± 0.603 | 0.52 ± 0.920 | 0.71 ± 1.653 | 0.469 |
SCr (umol/L) | 78.49 ± 20.795 | 78.72 ± 19.502 | 75.96 ± 17.009 | 81.02 ± 25.077 | 0.229 |
Uric acid (umol/L) | 337.73 ± 87.057 | 330.36 ± 76.779 | 332.97 ± 80.398 | 349.51 ± 101.219 | 0.261 |
BUN (mmol/L) | 4.57 ± 1.997 | 4.94 ± 2.192 | 4.30 ± 1.569 | 4.54 ± 2.183 | 0.088 |
AST (U/L) | 24.67 ± 9.167 | 24.70 ± 7.083 | 23.56 ± 8.580 | 25.81 ± 11.175 | 0.273 |
Total bilirubin (umol/L) | 12.20 ± 4.914 | 11.87 ± 4.609 | 11.94 ± 4.482 | 12.77 ± 5.575 | 0.373 |
